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Abstract
Objective—Research is increasingly linking autism spectrum disorders and other
neurodevelopmental disorders to synaptic abnormalities (“synaptopathies”). PSD-95 (postsynaptic
density-95, DLG4) orchestrates protein-protein interactions at excitatory synapses and is a major
functional bridge interconnecting a neurexin-neuroligin-SHANK pathway implicated in autism
spectrum disorders.
Method—The authors characterized behavioral, dendritic, and molecular phenotypic
abnormalities relevant to autism spectrum disorders in mice with PSD-95 deletion (Dlg4−/−). The
data from mice led to the identification of single-nucleotide polymorphisms (SNPs) in human
DLG4 and the examination of associations between these variants and neural signatures of
Williams’ syndrome in a normal population, using functional and structural neuroimaging.
Results—Dlg4−/− showed increased repetitive behaviors, abnormal communication and social
behaviors, impaired motor coordination, and increased stress reactivity and anxiety-related
responses. Dlg4−/− had subtle dysmorphology of amygdala dendritic spines and altered forebrain
expression of various synaptic genes, including Cyln2, which regulates cytoskeletal dynamics and
is a candidate gene for Williams’ syndrome. A significant association was observed between
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variations in two human DLG4 SNPs and reduced intraparietal sulcus volume and abnormal
cortico-amygdala coupling, both of which characterize Williams’ syndrome.
Conclusions—These findings demonstrate that Dlg4 gene disruption in mice produces a
complex range of behavioral and molecular abnormalities relevant to autism spectrum disorders
and Williams’ syndrome. The study provides an initial link between human DLG4 gene variation
and key neural endophenotypes of Williams’ syndrome and perhaps cortico-amygdala regulation
of emotional and social processes more generally.
Neurodevelopmental disorders such as fragile X syndrome and autism spectrum disorders
(hereafter referred to as “autism”) (1–3) are increasingly linked to synaptic abnormalities
(“synaptopathies”). Recent evidence indicates that copy number variants in synaptic genes
tend to be overrepresented in neurodevelopmental disorders (4–6). Postsynaptic function is
controlled by a highly complex, interconnected network of molecules (7). However, a
specific synaptic pathway comprising the predominantly presynaptic neurexins (NRXN) and
their postsynaptic binding partners, neuroligins (NLGN) and SHANK (8), has been
implicated in autism. Human loss-of-function variants in NLGN3, NLGN4, NRXN1, and
SHANK3 are associated with autism (3). In mice, Nlgn3 and Nlgn4 null mutation have been
found in some studies to cause autism-like traits (for example, references 9, 10–12), while
Shank1 deletion has been found to alter dendritic spine size and learning (13).
PSD-95 (postsynaptic density-95, DLG4), a member of the membrane-associated guanylate
kinase family of synaptic molecules, serves as a major functional bridge interconnecting the
neurexin-neuroligin-SHANK pathway (7) and orchestrates protein-protein interactions and
receptor stabilization at excitatory synapses (14). Gene variation and gene deletion of
another family member, SAP102 (DLG3), is associated with X-linked mental retardation in
humans (15) and autism-like abnormalities in mice (16), respectively. Microdeletion of
chromosomal region 3q29 containing the membrane-associated guanylate kinase SAP-97
(DLG1) is also associated with autistic traits (17). However, a possible role for PSD-95 in
autism and other neurodevelopmental disorders has not been studied.
In this study, we characterized mice with complete functional null mutation of PSD-95
(Dlg4−/−) for behavioral, dendritic, and molecular phenotypic abnormalities relevant to
neurodevelopmental disorders (18, 19). Our results then led us to examine associations
between human DLG4 gene variation and neural signatures of the neurodevelopmental
disorder Williams’ syndrome.
Method
For a full methodological description, see the data supplement that accompanies the online
edition of this article.
Mouse Phenotyping
Dlg4−/− were generated as described previously (20) and back-crossed to ~95% C57BL/6J
congenicity. Homozygous Dlg4 deletion adversely affected survival (only ~13% progeny
were Dlg4−/− at weaning), but surviving mice showed no obvious neurological or sensory
abnormalities, including in tests for startle, sensorimotor gating, pain, and olfaction (see
Table S1 and Figure S1 in the online data supplement).
Mice were tested for autism-related phenotypes in three major behavioral domains:
repetitive and social, locomotor and motor, and anxiety-related (19, 21). To minimize
potential carryover effects, multiple cohorts of age- and sex-matched Dlg4−/− and Dlg4+/+
littermates were tested, with more stressful tests later in sequences. (See figure footnotes for
number of mice tested.)
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Repetitive behaviors were examined through a discrete-trial T-maze, grooming, and marble
burying. Social behaviors in males were assayed through ultrasonic vocalizations to a
proestrous female, free social interaction, and social approach. Given evidence implicating
metabotropic glutamate receptor 5 in mouse fragile X syndrome and autism-related
abnormalities (1, 22), effects of receptor antagonism with 2-methyl-6-phenylethynylpyridine
(MPEP) (10 mg/kg) were tested on social approach. As a control task, the social approach
procedure was replicated with nonsocial objects.
Anxiety-related behaviors and stress reactivity were measured using light/dark exploration,
elevated plus-maze (starting location either facing an open or closed arm), stress-induced
hyperthermia, and restraint stress-induced corticosterone. Corticolimbic neuronal dendritic
spine density/morphology was measured using biolistic labeling of basolateral amygdala and
anterior cingulate cortex neurons.
Locomotor activity and motor coordination were examined using novel open field,
accelerating rotarod, balance beam, inverted wire-hang, and homecage activity. Effects of
MPEP on novel open-field behavior were tested. Nonquantitative histological analysis of the
cerebellum was performed using immunostaining of the major cerebellar cell types. Whole
brain volume and morphology were measured with structural MRI.
Microarray analysis was conducted on forebrain tissue using Affymetrix GeneChip. mRNA
changes in a subset of genes identified by microarray were confirmed by quantitative reverse
transcription polymerase chain reaction. Protein levels of Cyln2, a major candidate for
Williams’ syndrome (23), were analyzed by Western blot.
Data were analyzed using Student’s t tests, analysis of variance, Fisher’s least-significant-
difference post hoc tests, and Kolmogorov-Smirnov tests (spine analysis). Alpha was set at
0.05.
Human Neuroimaging
Participants from a multicenter study on intermediate neuroimaging phenotypes (24)
underwent genome-wide single-nucleotide polymorphism (SNP) analysis using Illumina
Human610-Quad BeadChip (Illumina, Inc., San Diego). On 3-T scanners, 115 participants
completed an imaging genetics protocol comprising several functional magnetic imaging
(fMRI) measurements, including an fMRI face matching task to engage the amygdala (25).
Connectivity between the amygdala and the subgenual anterior cingulate cortex was
analyzed using a seed region approach (24). Structural MRI was conducted on 93
participants. Voxel-based morphometry (26) focused on the occipital/intraparietal cortex.
Four DLG4 SNPs were available on the Illumina chip, of which three (rs17203281,
rs3826408, rs390200) met quality control criteria. Given high linkage disequilibrium (r=0.8)
between rs17203281 and rs3826408, only rs17203281 and rs390200 were analyzed.
Gentype distributions were in Hardy-Weinberg equilibrium for both SNPs. Because of the
small number of homozygote rs17203281 A-allele carriers (N=15), AA and AG were
combined for comparison with G allele homozygotes. Genotype effects on neural activation
and subgenual anterior cingulate cortex-amygdala connectivity were analyzed using the
general linear model in a second-level random-effects analysis, with genotype as the
covariate of interest and scanner site as a nuisance covariate. Results were corrected for
multiple comparisons using false discovery rate within prespecified regions of interest.
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Results
Repetitive and Social Behaviors
We phenotyped Dlg4−/− for various measures of repetitive and stereotypical behaviors. On a
T-maze spontaneous alternation test, Dlg4+/+ alternated significantly more than would be
expected due to chance (t=2.40, df=8, p<0.05), while Dlg4−/− alternated significantly less
than would be expected due to chance (t=2.65, df=7, p<0.05) (Figure 1A). When observed
for grooming behavior, Dlg4−/− groomed significantly more than did Dlg4+/+ in the
homecage (t=2.64, df=11, p<0.05) but not in the novel cage (Figure 1B). Lastly, in both a
novel cage (t=3.50, df=12, p<0.01) and homecage (t=3.05, df=12, p<0.01), Dlg4−/− buried
significantly fewer marbles than did Dlg4+/+ (Figure 1C).
We next examined Dlg4−/− for communicative and social phenotypes. Dlg4−/− had a
significantly longer latency to first vocalization (t=2.36, df=11, p<0.05) and made
significantly fewer vocalizations overall than Dlg4+/+ (Figure 1D–F). During a free dyadic
encounter, genotypes did not differ significantly in social behaviors directed toward the
stimulus mouse (Figure 1G). In a choice-based social approach test, both genotypes
investigated a mouse significantly more than they did an empty cage, but investigation of the
mouse was significantly greater in Dlg4−/− than in Dlg4+/+ (genotype-by-stimulus
interaction: F=10.87, df=1, 41, p<0.01) (Figure 1H). Both genotypes investigated a novel
mouse significantly more than they did a familiar mouse, but novel investigation was again
significantly greater in Dlg4−/− than in Dlg4+/+ (genotype-by-stimulus interaction: F=4.47,
df=1, 41, p<0.05) (Figure 1H). Total transitions between stimuli did not differ between
genotypes (Figure 1I). Following MPEP treatment, a separate cohort of Dlg4−/− again
showed relatively more social (compared with empty) and novel-social behavior (compared
with familiar), regardless of treatment (Figure 1J). Finally, in a replication of the social
approach test procedure, using nonsocial stimuli, both genotypes equivalently investigated
an object significantly more than an empty cage (stimulus effect: F=4.42, df=1, 19, p<0.05)
and a novel object over a familiar one (stimulus effect: F=11.25, df=1, 19, p<0.01) (Figure
1K).
Motor Functions and Cerebellar Morphology
Given the prevalence of motor deficits in autism and other neurodevelopmental disorders,
we conducted extensive analysis of Dlg4−/− in this domain. In a novel open-field test,
Dlg4−/− traveled significantly less (genotype main effect: F=8.89, df=1, 33, p<0.01) and
avoided the center more (t=2.39, df=33, p<0.05) than did Dlg4+/+ (Figure 2A). Following
treatment with MPEP, novel open-field locomotion was significantly increased in both
genotypes relative to vehicle (control condition) (drug effect: F=7.38, df=1, 25, p<0.05),
such that MPEP-treated Dlg4−/− were no different from vehicle-treated Dlg4+/+ (genotype
effect: F=11.37, df=1, 25, p<0.01) (Figure 2B). In contrast to reduced locomotion in a novel
open-field setting, locomotor activity in the familiar homecage environment did not differ
between genotypes (Figure 2C).
On the accelerating rotarod assay for motor coordination, Dlg4−/− had significantly lower
latencies to fall than did Dlg4+/+ on all trials, and both genotypes improved over trials
(genotype-by-trial interaction: F=9.52, df=9, 405, p<0.01) (Figure 2D). Dlg4−/− also made
significantly more foot-slips than did Dlg4+/+ on a balance beam test, but only on the
narrowest beam (genotype-by-beam width interaction: F=20.67, df=2, 42, p<0.01) (Figure
2E). Finally, Dlg4−/− had a significantly lower inverted hang latency than did Dlg4+/+ on an
inverted cage test for hypotonia (t=2.54, df=33, p<0.05) (Figure 2F).
Despite these behavioral abnormalities, there were no obvious genotype differences in
cerebellar morphology, as measured from parasagittal sections immunostained for calbindin
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(Purkinje cells) and neurofilaments (Purkinje cell axons, basket cell axons, and molecular
layer interneuron axons) and stained with DAPI (granule cell nuclei) (Figure 2G,H).
Structural MRI also revealed no genotype difference in gross morphology or total brain
volume (Figure 2I).
Anxiety- and Stress-Related Phenotypes
The final behavioral domain we examined was anxiety- and stress-related phenotypes. On
the light/dark exploration test, genotypes did not significantly differ either in dark time or
light/dark transitions (Figure 3A). However, Dlg4−/− spent less time (t=2.29, df=23, p<0.05)
and made fewer entries (not shown) into the open arms of the elevated plus-maze test than
did Dlg4+/+ when started facing a closed arm (Figure 3B). By contrast, when started facing
an open arm, a separate cohort of Dlg4−/− spent more time (t=4.03, df=40, p<0.01) and
made more entries (not shown) into the plus-maze open arms than did Dlg4+/+ (Figure 3B).
On a non-exploration-based assay for anxiety-related behavior and stress reactivity, Dlg4−/−
showed significantly greater stress-induced hyperthermia than did Dlg4+/+ (t=3.44, df=14,
p<0.01) (Figure 3C). Similarly, Dlg4−/− showed a significantly greater stress-induced serum
corticosterone response to restraint stress than did Dlg4+/+ (genotype-by-stress interaction:
F=9.67, df=1, 17, p<0.01) (Figure 3D).
To uncover possible neural correlates of these anxiety- and stress-related abnormalities, we
examined spine density and morphology of neurons in the anterior cingulate cortex and the
basolateral amygdala. Dlg4−/− had significantly larger spine headwidth than did Dlg4+/+ in
relatively long dendritic spines in basolateral amygdala neurons (D=0.42, p<0.01).
Genotypes did not differ in spine density distribution (Figure 3E,F). Neither spine headwidth
nor density in anterior cingulate cortex neurons differed between genotypes (see Figure S2
in the online data supplement).
Finally, we performed microarray analysis of forebrain tissue as a preliminary effort to
elucidate molecule disturbances in Dlg4−/−. Atp7a, Sdcbp, and Sptlc2 were significantly up-
regulated, and Nr4a1, Fos, Egr2, Per1, Junb, Cyln2, and Gadd45b were significantly down-
regulated in Dlg4−/− (Figure 3G). A subset of these genes were confirmed by quantitative
reverse transcription polymerase chain reaction (see Table S2 in the online data
supplement). Using Western blot, we confirmed significantly lower protein levels of Cyln2
in Dlg4−/− than in Dlg4+/+ (t=4.63, df=6, p<0.05) (Figure 3H).
Human Neuroimaging
While some of our data in Dlg4−/− supported our hypothesis that a null mutation of this key
synaptic molecule would lead to autism-like behavioral deficits, the pattern of at least some
of the behavioral phenotypes observed (see the Discussion section), coupled with the
reductions in the candidate gene, Cyln2, suggested that Dlg4−/− may produce abnormalities
related to Williams’ syndrome. This led us to ask whether human DLG4 variation could
contribute to neural endophenotypes of Williams’ syndrome in unaffected individuals. We
found that G allele carriers of one of the SNPs we identified, rs390200, showed significantly
lesser subgenual anterior cingulate cortex-amygdala connectivity than did homozygous A
allele carriers (peak voxel: x=0, y=24, z=−9; t=3.30, df=110, p<0.05) (Figure 4A,B). In
addition, rs17203281 homozygote G allele carriers had significantly lesser volume near the
right intraparietal sulcus relative to A allele carriers (peak voxel: x=43, y=−81, z=43;
t=4.57, df=87, p<0.05) (Figure 4C,D).
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Discussion
Our a priori hypothesis was that Dlg4 deletion would produce phenotypic abnormalities
relevant to neurodevelopmental disorders, particularly autism. We found that Dlg4−/−
exhibited a set of behavioral, dendritic spine, and molecular abnormalities, some of which
were autism-like, but others that are more related to other neurodevelopmental disorders,
notably Williams’ syndrome. Furthermore, we found that DLG4 variation was associated
with signature neural endophenotypes of Williams’ syndrome in a normal human
population.
Autism is characterized by repetitive and stereotypic behaviors (19, 21). On a T-maze test,
which measures the tendency of rodents to spontaneously alternate exploration of two goal
arms, Dlg4−/− exhibited modest but statistically significant repetitive exploration of the
same arm. Dlg4−/− also displayed excessive grooming behavior (as also found in putative
mouse autism models [27–29]). Notably, this was seen only in a homecage setting and not in
a novel context, possibly because of response competition with the suppression of behavior
in novel environments we observed in the mutants (see below). This could also possibly
account for the decrease, rather than repetitive-like increase, in marble burying in Dlg4−/−,
although that was seen in both novel and homecage environments. Nevertheless, these data
show that Dlg4 deletion produced some autism-like repetitive, stereotypical behaviors in
both the cognitive and noncognitive realms.
Abnormal communicative and social behavior are cardinal features of autism. Male Dlg4−/−
vocalized less in the presence of a proestrous female—a phenotype thought to be salient to
communication deficits in autism (19). Dlg4 deletion did not, however, produce an autism-
like reduction in social behavior, either during a free dyadic encounter or in a social
approach test (19). Unexpectedly, Dlg4−/− actually spent more time investigating the social
and novel-social stimulus than Dlg4+/+. Demonstrating that this increased social
investigation was not confounded by Dlg4−/− simply moving less in this test context (as they
do in novel, nonsocial contexts—see below), genotypes did not differ in the number of
transitions between stimuli. Furthermore, when we replaced social stimuli with inanimate
objects in the social approach procedure, Dlg4−/− did not show increased investigation of
nonsocial objects, indicating that a general preference for novelty per se did not drive the
social phenotype in the mutants. Thus, these data point to an unanticipated increase in
certain social behaviors in Dlg4−/−. Although previous studies have shown that treatment
with MPEP can prevent seizures and sensorimotor gating deficits in a mutant mouse model
of fragile X syndrome (1), we found that MPEP treatment did not decrease social behavior
in Dlg4−/− to Dlg4+/+ levels. Recent work has shown that social abnormalities in a model of
autism are similarly insensitive to this treatment (22), and additional studies are needed to
identify pharmacological and behavioral manipulations that effectively normalize such
disturbances.
In addition to repetitive motor actions, autism typically presents with various motor deficits,
including clumsiness; poor balance and coordination; unusual gait patterns, such as toe-
stepping; hypotonia; and either locomotor hyperactivity or motor retardation (21). A recent
meta-analysis concluded that motor incoordination should be considered a cardinal feature
of autism (30). Consistent with such problems in motor coordination, Dlg4−/− displayed
impaired performance on the accelerating rotarod test, as well as poor balance and gait on
the narrowest balance beam and mild hypotonia on an inverted hang test. Similar deficits are
seen in various glutamate signaling molecule mutants, such as lurcher and Grid2−/−, due to
cerebellar developmental malformation (31). However, our nonquantitative histological
analysis did not reveal gross abnormalities in cerebellar lamination or foliation in Dlg4−/−.
Gross brain morphology and volume, as measured by structural MRI, also appeared normal.
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While these data clearly demonstrate that Dlg4−/− phenocopy another major feature of
autism, this appears to reflect yet-to-be-determined subcellular or physiological anomalies in
the cerebellum or other brain regions controlling motor functions (e.g., striatum, motor
cortex) rather than any major anatomical aberration.
Also within the motor domain, Dlg4−/− had reduced locomotor activity in a novel open
field. This was associated with increased center avoidance, suggesting that the hypoactivity
could reflect anxiety-driven suppression of exploration rather than a more generalized
locomotor retardation that might be related to the motor incoordination. Affirming this
interpretation, Dlg4−/− showed normal levels of activity in the nonstressful homecage
environment and normal behavior in another locomotion-based but putatively less stressful
anxiety-related test: light/dark exploration. Moreover, treatment with the anxiolytic drug
MPEP (32) was sufficient to normalize open-field hypoactivity in Dlg4−/− to levels of
untreated Dlg4+/+—an effect that would be difficult to explain if the mutants were simply
motor compromised. We also tested Dlg4−/− in the elevated plus-maze, but behavior here
was difficult to interpret because of a strong influence of start location. However,
physiologic and neuroendocrine responses to stress were exaggerated in Dlg4−/−. Taken
together, this profile points to exaggerated stress reactivity and a task-dependent increase in
anxiety-like behavior in Dlg4−/− and provides a further parallel with the emotional
dysregulation, oftentimes increased anxiety (21), found in most neurodevelopmental
disorders.
While the neural basis of these behavioral abnormalities remains to be elucidated, we found
that Dlg4−/− had a subtle and specific alteration in the morphology of dendritic spines on
basolateral amygdala neurons—a key neural locus mediating emotional and social behavior.
Specifically, the heads of a subset of relatively long synaptic spines on basolateral amygdala
neurons were enlarged in Dlg4−/−. This change was not associated with an alteration in
spine density, nor in the spine density or morphology of spines in a prefrontal region that
interacts with the basolateral amygdala to regulate emotion, the anterior cingulate cortex
(33). It would be premature at this time to draw clear links between these changes and the
behavioral abnormalities exhibited by Dlg4−/−. It is an intriguing observation, however,
considering that dendritic spine dysmorphology is increasingly linked to
neurodevelopmental disorders (34) and given evidence that Dlg4 regulates microtubule
dynamics and motor proteins, such as dynein, that support the cytoskeletal machinery
modulating dendritic spine morphology (14, 35). It is also worth noting that spine head size
correlates with synaptic strengthening (36), particularly in the context of previous work
demonstrating that Dlg4−/− have enhanced long-term potentiation at hippocampal and
corticostriatal glutamate synapses, coupled with impaired spatial reference memory and
psychostimulant sensitization (20, 37).
Providing some initial insight into molecular factors that might contribute to the spine
morphology and/or behavioral disturbances caused by Dlg4 deletion, gene expression
analysis revealed forebrain expression in a suite of synaptic genes, including genes
associated with autism (GADD45B, Per1) and Menkes’ disease (Atp7a) (38, 39). Another
striking change was in Cyln2 (cytoplasmic linker protein of 115 kDa, CLIP-115), which was
decreased almost 50% at both the mRNA and the protein level. The human CYLN2 gene is
hemideleted within a microdeletion at chromosome 7q11.23 in Williams’ syndrome (23, 40–
42). In fact, along with LIMK1 and GTF2I, CYLN2 loss is a principal candidate for two
unusual features of this disorder—hypersociability coupled with heightened anxiety to
nonsocial stimuli (23). While we do not claim that loss of Cyln2 renders Dlg4−/− a model of
Williams’ syndrome, there are interesting parallels with the increased social and anxiety-
related phenotype we observed in these mice. In another parallel, Williams’ syndrome
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typically presents with motor incoordination manifested as abnormal gait and impaired stair
stepping.
DLG4 is not located within the Williams’ syndrome region or the orthologous region on
mouse chromosome 5. Previous studies have found that targeted heterozygous deletion of
Cyln2 impaired motor and fear-related behaviors (43), while deletion of Cyln2 along with
proximally neighboring Williams’ syndrome genes produced hypersociability (in choice, not
free interaction tests), heightened anxiety-like behavior (in the novel open-field test, not in
the light/dark test), and motor coordination deficits (44). These similarities to the Dlg4−/−
profile suggest a heuristic model in which Dlg4−/− deletion, via trans-acting epistatic or
molecular interaction, alters Cyln2 expression to drive, at least in part, the behavioral and
possibly the morphological disturbances displayed by Dlg4−/−. Since Cyln2 is thought to
support proper synaptic clustering of proteins by bridging microtubules and protein
complexes (43), functional interactions with Dlg4 would not be unexpected. However, to
our knowledge, this has not been directly demonstrated and remains a major question.
Extending these basic research findings, we provide preliminary evidence that variation in
the human DLG4 gene is associated with key neural Williams’ syndrome endophenotypes.
First, in a population of unaffected individuals, those carrying the G allele of rs390200 had
lesser subgenual anterior cingulate cortex-amygdala connectivity than homozygous A allele
carriers during a threatening faces task (25), mimicking the profile associated with the
anxiety and hypersocial phenotype of Williams’ syndrome (23). Reduced cingulate-
amygdala connectivity has also been linked to harm avoidance, an anxiety-related
personality variable, in healthy individuals studied with the same task as employed here
(45). Second, homozygote carriers of the rs17203281 G allele had lower volume near the
right intraparietal sulcus than A allele carriers, phenocopying the best-replicated structural
abnormality in Williams’ syndrome (23). Although the functionality of these two SNPs
remains to be determined, these data establish a link between DLG4 variation and both
functional and structural intermediate neural Williams’ syndrome phenotypes. This finding
raises some interesting questions for future work, such as whether these variants are present
in Williams’ syndrome patients and interact with the microdeletion to affect the clinical
phenotype.
Conclusions
Our study demonstrates that Dlg4 deletion in mice leads to a complex phenotypic profile of
increased repetitive behaviors on some measures, abnormal communication and social
behaviors, impaired motor coordination, and increased stress- and anxiety-related responses.
These behavioral disturbances were associated with dysmorphology of amygdala dendritic
spines and altered forebrain expression of a set of synaptic genes that included the Williams’
syndrome gene Cyln2. We also established an initial link between variation in two human
DLG4 SNPs and the Williams’ syndrome neural endophenotypes of reduced intraparietal
sulcus volume and abnormal cortico-amygdala coupling. Collectively, our findings offer
novel evidence of a contribution of DLG4 to certain behavioral abnormalities found in
neurodevelopmental disorders, such as autism and Williams’ syndrome, and the neural and
molecular mechanisms that underlie these disorders and perhaps normal variation in social
and emotional traits. More generally, given the position of Dlg4 as a major orchestrator of
synaptic function, our data provide further support for the conceptualization of
neurodevelopmental disorders as “synaptopathies.”
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FIGURE 1. Repetitive and Social Behaviors in Dlg4+/+ and Dlg4−/− Micea
a In panel A, Dlg4+/+ showed spontaneous alternation in a T-maze, while Dlg4−/− repeatedly
investigated the same arm (#p<0.05 compared with chance in same genotype; *p<0.05
compared with Dlg4+/+) (N=8–9). Panel B, Dlg4−/− groomed more in the homecage but not
in the novel cage (*p<0.05 compared with Dlg4+/+) (N=6–7). Panel C, Dlg4−/− buried fewer
marbles in novel and homecage (**p<0.01 compared with Dlg4+/+) (N=6–8). Panels D, E,
and F, Dlg4−/− were slower to first ultrasonic vocalization to a proestrous female and made
fewer ultrasonic vocalizations overall (**p<0.01, *p<0.05 compared with Dlg4+/+) (N=6–7).
Panel G, genotypes did not differ in social behavior in a free dyadic interaction (N=18).
Panel H, both genotypes investigated a mouse more than an empty cage, and a novel mouse
over a familiar one, but Dlg4−/− investigated the mouse and then the novel mouse more than
did Dlg4+/+ (##p<0.01 compared with empty/familiar in same genotype, **p<0.01
compared with Dlg4+/+) (N=17–26). Panel I, genotypes did not differ in transitions between
stimuli. Panel J, genotype differences described in panel H were unaffected by 2-methyl-6-
phenylethynylpyridine (MPEP) treatment (#p<0.05 compared with empty/familiar in same
genotype, *p<0.05 compared with Dlg4+/+) (N=5–6). VEH=vehicle (control condition).
Panel K, both genotypes investigated an object more than an empty cage, and a novel object
over a familiar one (#p<0.05 compared with empty cage, ##p<0.01 compared with object 1)
(N=10–11). Data are mean values.
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FIGURE 2. Motor Functions and Cerebellar Morphology in Dlg4+/+ and Dlg4−/− Micea
a In panel A, Dlg4−/− traveled less far and spent less time in the center (inset) in a novel
open field (*p<0.05 compared with Dlg4+/+) (N=13–22). Panel B, 2-methyl-6-
phenylethynyl-pyridine (MPEP) increased open-field activity in both genotypes,
normalizing Dlg4−/− activity to vehicle-treated (VEH; control condition) Dlg4+/+ levels
(N=7–8). Panel C, genotypes did not differ in homecage locomotor activity (N=9–11). Panel
D, Dlg4−/− had lower accelerating rotarod latencies (#p<0.05 compared with trial 1, *p<0.05
compared with Dlg4+/+) (N=21–26). Panel E, Dlg4−/− made more foot-slips on a narrow
balance beam (**p<0.01 compared with Dlg4+/+) (N=11–12). Panel F, Dlg4−/− had lower
wire-hang latency (*p<0.05 compared with Dlg4+/+) (N=13–22). Panels G and H, genotypes
did not differ in gross cerebellar morphology. Parasagittal sections immunostained for
calbindin (red=Purkinje cells) and neurofilaments (green=Purkinje cell axons, basket cell
axons around Purkinje cell somata [white arrow], and molecular layer [ML] interneuron
axons [yellow arrow]) and stained with DAPI (blue=granule cell nuclei in internal granule
layer [IGL], and sparse basket and stellate cells in ML) (scale bar=100 μm). PCL=Purkinje
cell layer. Panel I, structural MRI found no genotype differences in gross brain morphology
or volume. Data are mean values.
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FIGURE 3. Anxiety- and Stress-Related Phenotypes, Amygdala Spine Morphology, and
Forebrain Gene Expression in Dlg4+/+ and Dlg4−/− Micea
a In panel A, genotypes did not differ in dark time or light/dark transitions in the light/dark
test (N=9–22). Panel B, Dlg4−/− spent less time in the elevated plus-maze open arms when
started facing a closed arm (N=16–26) and more open time when started facing an open arm
(*p<0.05 compared with Dlg4+/+) (N=11–14). Panel C, Dlg4−/− showed greater stress-
induced hyperthermia (**p<0.01 compared with Dlg4+/+) (N=7–9). Panel D, Dlg4−/− had
greater corticosterone response to restraint stress (##p<0.01 compared with control, *p<0.05
compared with Dlg4+/+) (N=4–7). Panels E and F, Dlg4−/− showed larger headwidth of
relatively long dendritic spines in basolateral amygdala neurons but normal spine density
distribution (**p<0.01 compared with Dlg4+/+) (scale bar=10 μm) (N=4–6/genotype, 9–10
neurons, 21–37 dendrites). Panel G, Dlg4−/− differed in forebrain expression of 10 synaptic
and plasticity-related genes (N=3). Panel H, Dlg4−/− had reduced forebrain protein levels of
Cyln2 (**p<0.01 compared with Dlg4+/+) (N=4). Data are mean values.
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FIGURE 4. Human Variation in Cortico-Amygdala Connectivity and Gray Matter Volume
Observed by Neuroimaging in DLG4 SNPsa
a In panels A and B, DLG4 SNP rs390200 G allele carriers showed lesser subgenual anterior
cingulate cortex-amygdala connectivity than did homozygous A allele carriers during a
threatening face task (**p<0.01, *p<0.05 compared with AA) (N=115). Panels C and D,
homozygous DLG4 SNP rs17203281 G allele carriers had lower gray matter volume near
the intraparietal sulcus than did A allele carriers (*p<0.05 compared with AA/AG) (N=93).
Data are mean values. ROI=region of interest.
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